Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Effects of supernatants of polymorphonuclear neutrophils recruited by different inflammatory substances on mitogen responses of lymphocytes

    Two different substances, glycogen and thioglycollate, were used to recruit early peritoneal exudate cells (4 h). In the acute phase of the inflammatory response the cellular infiltrate is large, and the predo...

    Mary L. Rodrick, Ira B. Lamster, Stephen T. Sonis, Suzanne G. Pender in Inflammation (1982)

  2. No Access

    Book

  3. No Access

    Article

    Interaction of Ia antigen-bearing polymorphonuclear leukocytes and murine splenocytes

    Polymorphonuclear leukocytes (PMN) were induced in the peritoneum of a Balb/c mouse by ip injection ofFusobacterium nucleatum (FN) (>95% PMN). A subpopulation of PMN harvested bore Ia surface antigens and stimula...

    Dr. John E. Fitzgerald, Stephen T. Sonis, Mary L. Rodrick in Inflammation (1983)

  4. No Access

    Chapter

    Cancer, its Complications, and the Head and Neck

    Few diseases are as complex in their biology, physiology, pathology, or management as cancer [1, 2]. In addition, the disease concurrently has extensive psychological impact on patients. Consequently, the diag...

    Stephen T. Sonis in Head and Neck Management of the Cancer Patient (1986)

  5. No Access

    Article

    Nanoparticulate Hydroxyapatite Enhances the Bioactivity of a Resorbable Bone Graft

    A nanoparticulate-hydroxyapatite filler augmented osteointegration within a resorbable polymer based bone graft substitute designed for orthopaedic and periodontal applications. The unsaturated polyester poly(...

    Stephen A. Doherty, David D. Hile, Donald L. Wise in MRS Online Proceedings Library (2003)

  6. No Access

    Article

    The pathobiology of mucositis

  7. Mucositis is a common toxicity of antineoplastic radiation and drug therapies, and is associated with several adverse symptomatic, health and economic outcomes...

  8. Stephen T. Sonis in Nature Reviews Cancer (2004)

  9. No Access

    Article

    Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?

    Stephen T Sonis in Nature Clinical Practice Oncology (2005)

  10. No Access

    Article

    Palifermin in Myelotoxic Therapy-Induced Oral Mucositis

    Stephen T. Sonis in Drugs (2005)

  11. No Access

    Article

    Can oral glutamine prevent mucositis in children undergoing hematopoietic stem-cell transplantation?

    Stephen T Sonis in Nature Clinical Practice Oncology (2006)

  12. No Access

    Article

    Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis

    The pathobiology of alimentary tract (AT) mucositis is complex and there is limited information about the events which lead to the mucosal damage that occurs during cancer treatment. Various transcription fact...

    Richard M. Logan, Rachel J. Gibson, Joanne M. Bowen in Cancer Chemotherapy and Pharmacology (2008)

  13. No Access

    Article

    Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?

    Alimentary tract (AT) mucositis is a serious problem complicating cancer treatment, however, its pathobiology remains incompletely understood. Nuclear factor-κB (NF-κB) and pro-inflammatory cytokines are consi...

    Richard M. Logan, Andrea M. Stringer in Cancer Chemotherapy and Pharmacology (2009)

  14. No Access

    Article

    Role of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot study

    Oral mucositis can be a significant and dose-limiting complication of high-dose cancer therapy. Mucositis is a particularly severe problem in patients receiving myeloablative chemotherapy prior to bone marrow ...

    Rajesh V. Lalla, Carol C. Pilbeam, Stephen J. Walsh in Supportive Care in Cancer (2010)

  15. Article

    Open Access

    Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis

    To evaluate the effect of the anti-fibrotic protein serum amyloid P (SAP) on radiation-induced oral mucositis (OM) and fibrosis in a hamster cheek-pouch model.

    Lynne A Murray, Michael S Kramer, David P Hesson in Fibrogenesis & Tissue Repair (2010)

  16. No Access

    Chapter

    Animal Models of Toxicities Caused by Anti-Neoplastic Therapy

    Radiation and chemotherapy induce a wide range of acute and chronic toxicities. Not only are these associated with poor health outcomes but they also limit patients’ ability to tolerate treatment and incur sig...

    Stephen T. Sonis, Gregory Lyng, Kimberly Pouliot in Tumor Models in Cancer Research (2011)

  17. No Access

    Book

  18. No Access

    Chapter

    Introduction

    Since Madame Curie discovered radium in 1897 and the application of radiation to treat of cancers in the days before World War I, injury to the mucosal surfaces of the mouth (oral mucositis or OM) has been a p...

    Stephen T. Sonis in Oral Mucositis (2012)

  19. No Access

    Chapter

    The Epidemiology and Risk Assessment of Mucositis

    OM is among the most common and dreaded toxicities of cancer therapy [1]. It occurs in almost all patients who receive radiation therapy in which areas of the oral or oropharyngeal mucosa are included in the t...

    Stephen T. Sonis in Oral Mucositis (2012)

  20. No Access

    Chapter

    The Elements of Examination of the Oral Cavity

    The clinical examination of the oral cavity is straightforward and easily accomplished with minimum tissue manipulation or discomfort to patients. As with any physical examination, a standardized sequence and ...

    Stephen T. Sonis in Oral Mucositis (2012)

  21. No Access

    Chapter

    Patient-Reported Outcomes

    While we rely heavily on clinician evaluation of the mouth to define the course of mucositis, patient-reported outcomes (PROs) provide an important component to the overall assessment of the condition. PROs ar...

    Stephen T. Sonis in Oral Mucositis (2012)

  22. No Access

    Chapter

    Current Approaches to the Management of Oral Mucositis

    Despite its frequency, impact on patients and health and economic costs, there are currently limited evidence-based options for the prevention or treatment of OM. A number of guidelines for the management of O...

    Stephen T. Sonis in Oral Mucositis (2012)

previous disabled Page of 3